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The administration of acetylstrophanthldin into the left lateral ventricle of dogs anesthetized with alpha- 
ehloralose produces ventricular arrhythmlas and a marked pressor response. The pressor response is not prevented 
by the intravenous or intraventdcular administration of d,l-propranolol nor by reserpine-pretreatment. However, 
the centrally-induced pressor response is reversed by intravenously administered d,l-propranolol but not by d-pro- 
pranolol. The mechanism by which d,l-propranolol exerts this effect is discussed. The ventrlcular arrhythmias did 
not occur after reserpine-pretreatment or after the intraventricular injection of d,l-propranolol. The arrhythmias 
were affected by neither the intravenous admlmstration of d,l-propranolol nor the intraventricular reJection of 
d-propranolol. 
Cardiac glycosides Reserpine Lateral cerebral ventricle 
Propranolol Ventricular arrhythmias Blood pressure 
1. INTRODUCTION 
The most frequently occurring mode of death fol- 
lowing the intravenous administration of cardiac gly- 
cosides to dogs is ventricular fibrillation (Erlij and 
Mendez, 1964; Stickney et al., 1966). However, fol- 
lowing either depletion of catecholamines with reser- 
pine or beta-adrenerglc receptor blockade with pro- 
pranolol, cardiac arrest becomes the most frequent 
cause of death induced by cardiac glycosides (Stick- 
ney et al., 1966; Nash et al., 1964). The relationship 
between catecholamines and mode of death was first 
noted by Mendez et al. (1961) who observed that 
dogs with bilateral vagotomy died in ventricular 
fibrillation, but that ventricular fibrillation never 
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occurred after bilateral cardiac sympathectomy and 
ligation of the adrenal glands. 
To explain the relation of sympathetic activity to 
the occurrence of ventricular fibrillation, Boyajy and 
Nash (1966) and Mendez et al. (1961) have suggested 
that death induced by cardiac glycosides is, in part, 
mediated by central nervous system mechanisms 
which in some way modify peripheral sympathetic 
nervous system activity. To further investigate this 
problem the present experiments studied the cardio- 
vascular responses that followed the injection of 
acetylstrophanthidin into the left lateral ventricle. 
2. METHODS 
The experiments were performed on male, beagle- 
type dogs that weighed between six and twelve kilo- 
grams. The animals were anesthetized with alpha- 
chloralose, 100 mg/kg administered intravenously. 
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Blood pressure was recorded from the right femoral 
artery with a pressure transducer. The blood pressure 
and Lead II electrocardiogram were recorded contin- 
uously on a Grass Model 7 polygraph. The Lead II 
electrocardiogram was also monitored contmuously 
on an oscilloscope. A catheter was placed in the left 
jugular vem for the systemic administration of drugs. 
Decamethonlum, 1.0 mg/kg, was administered intra- 
venously to induce neuromuscular blockade. A Palmer 
respirator pump was used to ventilate the animal with 
room air. 
The term central injection refers to the admini- 
stration of a drug into the left lateral ventricle of the 
brain. The left lateral ventricle was located by using 
Horsely-Clarke coordinates (as modified by Lim et al., 
1960) on a stereotaxic instrument. The dose of ace- 
tylstrophanthidin rejected centrally was 10.0/ag/kg in 
an rejection volume of 0.5-0.9 ml. 
The effects of intraventricularly administered pro- 
pranolol on pressor responses and cardmc arrhyth- 
mlas elicited by the central injection of acetylstro- 
phanthidin were studied. In two different series of 
experiments, d-propranolol and d,l-propranolol were 
injected into the left lateral ventricle, and acetyl- 
strophanthidin injected into the same ventricle 15 
rain later. In other experiments, animals were pre- 
treated with reserpine, 0.1 mg/kg intramuscularly on 
two consecutive days; the animals were used on the 
fourth day. 
In another group of animals the racemic mixture 
of propranolol was administered intravenously to 
block beta-adrenerglc receptors before the central re- 
jection of acetylstrophanthidin. 
In two additional groups of animals, either d-pro- 
pranolol or d,l-propranolol was administered intra- 
venously after the central injection of acetylstrophan- 
thidm. 
Acetylstrophanthidin was generously supplied by 
Eli Lilly and Company of Indianapolis, Indiana Both 
the racemic mixture and the d-isomer of propranolol 
(Inderal) were generously supplied by Ayerst Labora- 
tories in New York, New York. 
3. RESULTS 
3.1. Control responses to the injection of  acetylstro- 
phanthidin into the left lateral cerebral ventricle 
The dose of acetylstrophanthidin used here, 10 
/ag/kg, produces no observable responses when in- 
jected mtravenously; however, in six out of six un- 
treated animals marked cardiovascular responses fol- 
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Fig. 1. The Lead II electrocardiogram is illustrated in the upper part of each Panel; arterial blood pressure is shown in the lower 
part. Panel A represents the control record. Nodal bradyeardia is shown in Panel B. Panel C tllustrates the marked pressor res- 
ponse and the ventncular tachycardia. After 8 min, Panel D, the ventricular rhythm had reverted to a normal sinus rhythm; sys- 
tolic pressure was slightly decreased. 
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lowed the injection of  this dose of  the drug into the 
left lateral ventricle of  the brain. A typical response 
is represented in fig. 1. The blood pressure sometimes 
showed a moderate decrease within the first ten min- 
utes after the intraventricular injection o f  acetylstro- 
phanthidin; this response was not consistent. A 
marked presser response, 9 0 - 2 0 0  mm Hg, was always 
elicited by the central injection, of  acetylstrophanthi- 
din, it followed the depressor response when the 
latter occurred. After 4 5 - 6 0  min at its maximum 
level, the blood pressure would begin to decrease 
spontaneously, but never decreased to control levels 
even after 4 hours had elapsed. 
The eady electrocardiographic changes that oc- 
curred within the first 1 0 - 2 0  min following the in- 
traventricular injection of  acetylstrophanthidin were 
not uniform from one experiment to another; sinus 
bradycardia, sinus tachycardia, nodal bradycardia, 
and ventricular rhythms were all observed dunng this 
period in different animals. The latter changes were 
consistent and usually began as the blood pressure 
began to rise. There was a marked sinus tachycardia 
that progressed to a bigeminal rhythm; the sequence 
of  events culminated in ventncular tachycardia or a 
multifocal ventricular rhythm. Neither ventricular 
fibrillation nor cardiac arrest ever resulted from the 
intraventricular injection ofacetylstrophanthidin. The 
intraventricular injection of  an equal volume of  phy- 
siological saline did not produce these cardiovascular 
changes. The centrally-induced arrhythmias reversed 
spontaneously after 1 0 - 3 0  min. Once reversed, the 
arrhythmias could not be ehcited again with subse- 
quent injections of  acetylstrophanthidin, even when 
larger doses were used. 
3.2. Bilateral vago tomy 
Bilateral cervical vagotomy was performed in two 
animals. This procedure abolished the excessive brady- 
cardia and atrioventricular nodal block induced by 
the central administration of  acetylstrophanthidin, 
but it prevented neither the presser response nor the 
occurrence of  centrally-induced ventricular arrhyth- 
mias. 
3.3. Systemic administration of  sympatholytic drugs 
Reserpine, 0.1 mg/kg, was administered intra- 
muscularly to five dogs on two consecutive days, ex- 
periments were performed on the fourth day. Cen- 
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Fig. 2 Panels A and B are records from two different dogs that had been pretreated with reserpine. In both Panels the blood 
pressure scale in Part 3 is twice that in Parts 1 and 2. Panel A: Part 1 was taken from the control record; heart rate, 70 beats/rain. 
Acetylstrophanthidm was injected into the left lateral ventricle at the arrow between Parts 1 and 2. Panel 2 shows the slow 
bigeminal rhythm that developed; the blood pressure was unchanged. Part 3 illustrates the marked presser response; although no 
ventricular rhythm developed, the heart rate increased to 120 beats]min. Panel B: Part 1 represents the control record. Acetyl- 
strophanthidin was injected into the left lateral ventricle at the arrow between Parts 1 and 2. Sinus bradycardia is shown in Part 2. 
the blood pressure was unchanged. Part 3 shows the sinus tachycardia and the marked presser response. 
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trally rejected acetylstrophanth]din did not  produce 
arrhythmias following reserpine pretreatment ,  how- 
ever, a sinus tachycardia and a pressor response were 
elicited. Fig. 2 shows segments o f  records taken dur- 
ing two separate experiments 
Systemic pretreatment  of  five different animals 
with d,/-propranolol (1.0 mg/kg intravenously 20 min 
before the central injection of  acetylstrophanth]dln) 
did not  give consistent results. Neither ventricular ar- 
rhythmias nor pressor responses were elicited by the 
intraventricular injection o f  acetyls trophanthldln fol- 
lowing d,/-propranolol pret reatment  m two experi- 
ments,  m both experiments a marked sinus brady- 
cardm developed. However, the pressor responses and 
ventrlcular arrhythmias did develop after the central 
admmistrat]on of  acetylstrophanthidin in two addi- 
tional animals that had been pretreated with d,l-pro- 
pranolol. A fifth animal was pretreated with a larger 
dose of  d,/-propranolol,  2.5 mg/kg,  all centrally in- 
duced responses occurred as in control  anamals. 
3.4 lntraventncular administration of  sympatholytic 
drugs 
The effects of  the intraventricular injection of  
both  d- and d,/-propranolol on cardiovascular res- 
ponses produced by centrally administered acetyl- 
s trophanthidin were studied. The total dose of  d,l- 
propranolol  injected into the left lateral ventricle was 
1.0 mg; if all o f  this dose were to gain access to the 
systemic circulation, the maximum dose attained 
would be 0+11 mg/kg. This dose is not  sufficient to 
produce a significant blockade of  beta-adrenergic re- 
ceptors (Whatsitt and Lucchesi, 1967). Isoproterenol,  
0.25/ag]kg, was injected intravenously into each ani- 
mal before and after the central administrat ion of  
d,/-propranolol;  there was no significant difference 
between the two chronotropic responses to isopro- 
terenol. In four different dogs, the central injection 
of d,/-propranolol appeared to at tenuate,  in varying 
degrees, the cardiovascular changes produced by the 
central administration o f  acetylstrophanthidin.  In one 
experiment,  the development of  ventricular arrhyth- 
mlas and pressor response was prevented; m two 
others, the pressor response developed but  the ven- 
tricular arrhythmias did not;  in the fourth, the pres- 
sor response as well as some isolated ventncular  beats 
occurred and these beats developed into a short run 
of  ventricular tachycardia Although the ventricular 
arrhythmias appeared to be modified by  the intraven- 
tncular  injection of  d,/-propranolol,  the centrally-in- 
duced bradycardla was not. The results are similar to 
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Fig. 3. Panels A and B show records taken from the same ammal. The upper part of each record shows the arterial blood pressure 
m mm Hg; the Lead I1 electrocardiogram IS shown in the lower part. Panel A Part 1 represents the control record. At arrow be- 
tween Parts 1 and 2 acetylstrophanthidm was injected into the left lateral ventricle. Part 2 was recorded after the ventricular 
rhythm had changed to a sinus tachycardia; blood pressure is still elevated. Part 3 shows the effect of a 5 min infusion ofd-pro- 
pranolol, 1.0 mg/kg. Part 4 was taken 5 min after the d-propranoiol infusion had been completed Panel B. Part 1 is a contmuaUon 
of the record shown in A-4. Part 2 shows the marked decrease in blood pressure elicited by the 5 min infusion of d,l-propranolol, 
1.0 mg/kg. Part 3 was recorded 5 min after completion of d,l-propranolol administration. 
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isomer of  propranolol was administered centrally to 
five animals; it did not alter the cardiovascular re- 
sponses to the intraventricular injection of acetylstro- 
phanthidin. 
3.5. Modification o f  pressor response 
A marked pressor response was consistently pro- 
duced by the intraventricular administration of acetyl- 
strophanthidin. The response was not consistently 
modified by any of the procedures employed. Al- 
though no form of pretreatment prevented the pres- 
sor response from occurring, the response could be 
reversed once it had been produced by d,l- but not 
d-propranolol. One and one-half min after the onset 
of centrally-induced ventrlcular arrhythmias, 1.0 mg/ 
kg of either d- or d,l-propranolol was injected intra- 
venously over a five-min period; five animals received 
the d-isomer and five additional animals received the 
racemic mixture. The d-isomer had very little effect 
on the pressor response (p < 0.1); however, d,l- 
propranolol significantly lowered the elevated blood 
pressure (p < 0.01). Fig. 3 illustrates the differential 
effect of d- and d,l-propranolol in reversing the cen- 
trally-reduced pressor response. The depressor effect 
appeared when a dose as small as 0.2 mg/kg, of d,l- 
propranolol was administered. The decrease in dias- 
tolic pressure was less than the decrease in systolic 
pressure; consequently, the pulse pressure was greatly 
reduced in all of  the experiments. The blood pressure 
was never reduced below control values. 
4. DISCUSSION 
The cardiac arrhythmias and the pressor response 
elicited by the central injection of acetylstrophanthi- 
din are similar to the changes evoked by the injection 
of other cardiac glycosides into the cerebral ventricles 
(Weinberg and Haley, 1955; Bircher et al., 1963). 
The drug-induced EKG changes closely resemble 
those that follow electrical stimulation of the lateral 
and posterior hypothalamus (Parker et al., 1962; 
Attar et al., 1963). Manning and Cotton (1962) and 
Bircher et al. (1965) have suggested that the ventricu- 
lar arrhythmias induced by hypothalamic stimulation 
and those following the injection of cardiac glyco- 
sides into a cerebral ventricle are due to the activation 
of parasympathetic as well as sympathetic cardiac 
nerves. In the present investigation, only the excessive 
sinus bradycardia and atrioventricular nodal block 
induced by the central administration of acetylstro- 
phanthidin were abolished when bilateral cervical 
vagotomy was performed before the intraventricular 
injection of acetylstrophanthidin. These results are in 
agreement with those of Hockman et al. (1966), but 
not those of Manning and Cotton (1962) or those of 
Parker et al. (1962). 
Electrical stimulation of the hypothalamus as well 
as the intraventricular injection of cardiac glycosides 
produces a continuum of electrocardiographic changes 
that begins with sinus tachycardia and ends with a 
multifocal ventricular rhythm. Hockman et al. (1966) 
found that each arrhythmia could be elicited out of 
sequence by electrical stimulation with a specific 
stimulus intensity. The responses further along the 
continuum required greater stimulus intensities; thus, 
sinus tachycardia required the least and multifocal 
ventricular rhythm, the greatest stimulus intensity. 
Hockman et al. (1966) believe the dominant factor in 
the genesis of these centrally-induced arrhythmias to 
be the concentration of norepinephrme at the neuro- 
effector sites within the myocardium. 
If the central administration of cardiac glycosides 
or electrical stimulation of the hypothalamus were 
causing the release of norepinephrine from adrenergic 
cardiac nerve endings, then the intravenous admini- 
stration of d,/-propranolol or catecholamine-depletion 
by reserpine would be expected to prevent or modify 
the centrally induced arrhythmias. Indeed, Hockman 
et al. (1966) found that after d,l-propranolol (1.0 
mg/kg intravenously) electrical stimulation of loci in 
the diencephalon and mesencephalon had no obser- 
vable effect on either heart rate or rhythm. However, 
in the present investigation d,l-propranolol (1.0 mg/kg 
intravenously) prevented the occurrence of ventricu- 
lar arrhythmias following the central administration 
of acetylstrophanthidin in two animals, but it was in- 
effective in blocking the arrhythmic response in three 
other animals. Different experimental methods might 
possibly explain the discrepancy between the results 
of the two different laboratories. However, if both 
stimuli produce arrhythmias by the same mechanism, 
i.e. norepinephrine which is released from cardiac 
sympathetic nerve endings, then response to either 
stimulus should be blocked by the intravenous admin- 
istration of an adequate dose of d,l-propranolol. 
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Reserpine-pretreatment prevented the development of 
ventricular arrhythmlas following the central rejection 
of acetylstrophanthidin to dogs with intact vagii; 
however, a sinus tachycardla developed andthe  pres- 
sor response was unchanged. Although the dose of 
reserpine used was sufficient to deplete myocardial 
and brain catecholamine stores, it is possible that the 
adrenal medulla was only partially depleted (Muscholl 
and Vogt, 1958). If this be the case, it is possible that 
the intraventrlcular injection of acetylstrophanthidin 
caused a release of adrenal medullary catecholamines. 
One must then postulate that the amount of amines 
released was sufficient to produce a pressor response 
and a sinus tachycardia but not sufficient to produce 
ventricular arrhythmms. 
Although the concentration of norepinephrlne at 
the neuroeffector sites within the myocardium may 
play a role in centrally-induced arrhythmias, a central 
site of action for an adrenergic transmitter cannot be 
ruled out. Perhaps centrally-administered cardiac gly- 
cosides produce cardiac arrhythmias by effecting the 
central release of a substance, probably an adrener- 
glc mediator, that is depleted by reserpine-pretreat- 
ment. Following reserpme-pretreatment, centrally ad- 
mimstered acetylstrophanthidin did not produce ven- 
tricular arrhythmlas. Further evidence for this sugges- 
tion comes from experiments in which acetylstro- 
phanthidin administered centrally following the intra- 
ventricular rejection of d,l-propranolol failed to pro- 
duce ventricular arrhythmias. Central administration 
of d-propranolol did not modify the ventricular ar- 
rhythmias produced by the intraventricular injection 
of acetylstrophanthidin. Although the racemic mix- 
ture of propranolol is found to be concentrated in 
brain tissue (Black et al., 1965), intravenously ad- 
ministered d,l-propranolol did not prevent the occur- 
rence of cardiac arrhythmias following the central ad- 
ministration of acetylstrophanthldin. Cerebral distri- 
bution of drug following an intraventricular rejection 
would not be expected to be the same as that fol- 
lowing an intravenous injection, perhaps this differ- 
ence contributes to the discrepancy in the results. 
There is no doubt that cardiac glycosides injected 
into the cerebral ventricular system are capable of 
producing severe cardiac arrhythmias. The mecha- 
nism by which these arrhythmias is produced is not 
clearly understood, some of the evidence presented 
here suggests that an adrenergic transmitter may be 
involved. The fact that centrally-injected cardiac gly- 
cosides elicit cardiac arrhythmlas, in conjunction with 
results from experiments in which animals without a 
functioning sympathetic nervous system die in cardiac 
arrest suggest that lethal doses of cardiac glycosides 
may act, m part, on those areas of the central nervous 
system which regulate and modify peripheral sym- 
pathetic nervous system activity. 
Although the cardiac arrhythmias produced by the 
lntraventricular rejection of acetylstrophanthidin were 
modified by reserpine-pretreatment and by intraven- 
trlcular d,/-propranolol, the centrally-induced pressor 
response was not altered by any form of  drug pre- 
treatment used m the investigation. Sharpless and 
Rothballer (1961) have suggested that the pressor 
response is mediated by a non-catechol humoral sub- 
stance. More recently Melville et al. (1963) have attri- 
buted the centrally-induced pressor response to in- 
creased sympathetic outflow. In the present investi- 
gation, reserpme-pretreatment had no effect on the 
pressor response. However, on the basis of these re- 
suits alone, one cannot definitely rule out epinephrine 
or noreplnephrine as the peripheral mediator of the 
pressor response because it is possible that the dose 
of reserpine used was not sufficient to thoroughly 
deplete the adrenal medulla. It is noteworthy that 
the racemic mixture, but not d-propranolol, was able 
to reverse the pressor response once it had occurred. 
The reversal by d,l-propranolol is interesting in that 
the blood pressure never fell below control values. 
The mechamsm by which d,l-propranolol reversed 
the pressor response ~s not clear. One possible ex- 
planation is that increased myocardial contractility 
and heart rate produce the pressor response. There- 
fore, d,/-propranolol reverses the pressor response by 
blocking myocardial beta-adrenerglc receptors. How- 
ever, if increased myocardial sympathetic activity 
alone were responsible for the centrally-reduced pres- 
sor response, pretreatment w~th d,l-propranolol 
should prevent it. 
In conclusion, the cardiac arrhythmias produced 
by the central administration of acetylstrophanthidin 
were prevented by reserpine-pretreatment and by the 
intraventricular injection of d,l-propranolol. No form 
of pretreatment prevented the centrally-induced pres- 
sor response; however, slow intravenous administra- 
tion of d,l-propranolol reversed the pressor response 
once it occurred. It would appear that norepinephrine 
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or epinephrine is involved in the cardiovascular 
changes produced by the injection of acetylstrophan- 
thidin into the left lateral cerebral ventricle. One 
cannot assign a discrete locus of activity to the cate- 
cholamines; that is, they could be acting within the 
central nervous system as well as peripherally. 
REFERENCES 
Attar, H., M.Butierrez, S.BeUet and J.Ravens, 1963, Effect of 
stimulation of hypothalamus and reticular activating sys- 
tem on production of cardiac arrhythmia, Circulation 
Res. 12, 14. 
Bircher, R., C.Chal and S.Wang, 1965, Effects of hexameth- 
onium and tetraethylammonium on cardiac arrhythmias 
produced by pentylenetetrazol, picrotoxin and deslano- 
side in dogs, J. Pharmacol. Exp. Ther. 149, 91. 
Bircher, R., T.Kanai and S.Wang, 1963, Mechanism of car- 
dlac arrhythmias and blood pressure changes induced m 
dogs by pentylenetetrazol, picrotoxin, and deslanoside, 
J. Pharmacol. Exp. Ther. 141, 6. 
Black, J., W.Duncan and R.Shanks, 1965, Comparison of 
some properties of pronethalol and propranolol, Brit. J. 
Pharmacol. 25,577. 
Boyajy, L. and C.Nash, 1966, Alteration of ouabain toxicity 
by cardiac denervation, Toxicol. Appl. Pharmacol. 6, 163. 
Erlij, D. and R.Mendez, 1965, The modification of digitalis 
intoxicataon by excluding adrenergic influences on the 
heart, J. Pharmacol. Exp. Ther. 144, 97. 
Hockman, C., H.Mauck and E.Hoff, 1966, ECG changes re- 
sulting from cerebral stimulation. II. A spectrum of ven- 
tncular arrhythmias of sympathetic origin, Amer. Heart 
J. 71,695. 
Lira, R., C.Liu and R.Moffitt, 1960, A stereotaxic atlas of 
the dog's brain (Charles C.Thomas, Springfield, Illinois) 
Manning, J. and M.Cotton, 1962, Mechanism of cardiac ar- 
rhythmias induced by diencephalic stimulation, Amer. J. 
Physiol. 203, 1120. 
Melville, K., B.Blum, H.Shister and M.Silver, 1963, Cardiac 
ischemic changes and arrhythmias induced by hypothal- 
amic stimulation, Amer. J Cardiol. 12, 781. 
Mendez, C., J.Aceves and R Mendez, 1961, The anti-adrener- 
gic action of digitalis on the refractory period of the 
A-V transmission .system, J. Pharmacol. Exp. Ther. 131, 
199. 
Muscholl, E. and M.Vogt, 1958, The action of reserpine on 
the peripheral sympathetic system, J Physiol. (London) 
141, 132. 
Nash, C., J.Alley and E.Manley, 1964, The suppression of 
ouabain toxicity by oxytocin and reserpine, Toxicol 
Appl. Pharmacol. 6, 163. 
Parker, I., Jr., C Gunn and T.Lynn, 1962, Experimental cen- 
trogenic arrhythmias, Clin. Res. 10, 179. 
Sharpless, S. and A.Rothballer, 1961, Humeral factors re- 
leased from intracranial sources during stimulation of 
reticular formation, Amer. J. Physiol. 200, 909. 
Stickney, J,  B.Lucchesi and G.Abrams, 1966, Pharmacolo- 
gical alteration of the response of the mammalian heart to 
acetylstrophanthidln, Fed. Proc 25,621. 
Weinberg, S. and T.Haley, 1955, Centrally mediated effects 
of cardiac drugs: strophanthin-K, quinidine, and procaine 
amide, Circulation Res. 3, 103. 
